Articles tagged "Hepatitis B"

2022 American Transplant Congress
Long-Term Outcomes of Liver Transplantation (LT) Using Grafts from Donors with Active and Chronic Hepatitis B Virus (HBV) Infection; Multi-Center Cohort Study
S. Suh¹, S. Gang², Y. Choi², S. Hong², N. Yi², K. Lee², K. Suh²
¹Chung-Ang University, Seoul, Korea, Republic of, ²Seoul National University, Seoul, Korea, Republic of
*Purpose: Liver grafts from donors with hepatitis B infection contributed to expand the donor pool under the Hepatitis B immunoglobulin (HBIG) and antiviral agents (NA:…
2022 American Transplant Congress
Safety and Efficacy at 4 Years in Post-Liver Transplant Patients with Chronic Kidney Disease Receiving Tenofovir Alafenamide (TAF) for HBV Prophylaxis
E. Gane¹, B. George¹, D. Ray-Chaudhuri¹, T. Mules¹, C. D. Holt², H. Wang², V. Suri², A. Gaggar², A. Osinusi², J. Flaherty²
¹Auckland City Hospital and University of Auckland, Auckland, New Zealand, ²Gilead Sciences, Inc., Foster City, CA
*Purpose: Recommended antiviral prophylaxis to prevent recurrent HBV infection after liver transplantation includes tenofovir disoproxil fumarate (TDF). However, given risks of bone/renal toxicity associated with…
2022 American Transplant Congress
Immunity Rates to Hepatitis B Among Solid Organ Transplant Recipients
S. Kopf¹, J. Walker², K. Bruxvoort³, H. Budhwani³, A. Nellore⁴
¹Infectious Disease, University of Alabama at Birmingham Hospital, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL, ³University of Alabama at Birmingham Hospital, Birmingham, AL, ⁴University of Alabama, Birmingham, AL
*Purpose: Immunosuppression after transplantation decreases vaccine responsiveness. Thus, to be best protected from post-transplant communicable diseases, vaccination of organ transplant candidates in the pre-transplant period…
2022 American Transplant Congress
Compliance with OPTN Infectious Disease Testing
L. Irwin
Massachusetts General Hospital, Boston, MA
*Purpose: Effective 3/1/21 OPTN policy requires all transplant recipients to have pre-transplant and post-transplant infectious disease testing performed at specific intervals: upon admission and prior…
2022 American Transplant Congress
The Prevalence And Risk Factors Of De Novo Hepatitis B Virus Infection In Kidney Transplantation From Hepatitis B Antigen-positive Donors To Hbsag-negative Recipients
J. Wu¹, S. Yin¹, F. Zhang¹, L. Wu¹, X. Wang², T. Lin¹
¹urology, west china hospital, Chengdu, China, ²Urology, West China Hospital, Chengdu, China
*Purpose: To explore the prevalence and risk factors of de novo HBV infection (DNH) in kidney transplantation (KT) from HBsAg⁺ donors (D[HBsAg⁺]) to HBsAg-negative recipients…
2021 American Transplant Congress
Use of Hepatitis B N.A.T. Positive Kidneys in Hepatitis B Immune Recipients
E. Stephenson¹, B. Nangunuri², T. McCune³
¹Nephrology and Critical Care, Eastern Virginia Medical School, Norfolk, VA, ²Eastern Virginia Medical School, Norfolk, VA, ³Nephrology, Eastern Virginia Medical School, Norfolk, VA
*Purpose: There is an increasing demand for kidney donations as roughly 4000 people die on the waitlist each year while the number of kidneys being…
2021 American Transplant Congress
De Novo Hepatitis B Infection Following Liver Transplant with Hepatitis B Core Antibody Positive Graft
L. J. Myhre¹, K. D. Watt², B. A. Aqel³
¹Pharmacy, Mayo Clinic, Rochester, MN, ²Gastroenterology/Hepatology, Mayo Clinic, Rochester, MN, ³Gastroenterology/Hepatology, Mayo Clinic, Phoenix, AZ
*Purpose: The risk of de novo HBV infection in liver transplant recipients of Hepatitis B core antibody (HBcAb) positive donor organs is tempered by availability…
2021 American Transplant Congress
Impact of Non-active Hepatitis B on Patient Survival After Renal Transplantation
A. Paschereit¹, K. Budde², M. Duerr², M. G. Naik²
¹Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité University Medicine Berlin, Berlin, Germany, ²Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Dialysis patients (pts) have an increased risk for hepatitis B (HB) infection and impaired response to HB vaccine compared to the general population. As…
2020 American Transplant Congress
Impact of Non-Active Hepatitis B after Renal Transplantation
M. G. Naik, W. Duettmann, M. Mayrdorfer, F. Halleck, K. Budde, M. Duerr
Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Hepatitis B (HB) is more frequent in dialysis patients (pts) than in the general population. Patient and graft survival in pts with chronic HB…
2020 American Transplant Congress
Kidney Transplantation from HBsAg+ Living Donors to HBsAg- Recipients: A Propensity Score-Matched Study at a High-Volume Center in China
X. Wang, J. Liu, T. Song, Y. Fan, Z. Huang, T. Lin
Urology, West China Hospital, Chengdu, China
*Purpose: Data on kidney transplantation (KTx) from hepatitis B surface antigen (HBsAg)+ donors to HBsAg- recipients [D(HBsAg+)/R(HBsAg-)] are limited. We aimed to report the outcomes…

1
2
3
…
6
Next Page »